TABLE 1.

Clinical characteristics of Aspergillus spondylitis in immunocompetent patients.

Reference	Year	Age/sex	Predisposing conditions	Presentation	Radiology	Diagnosis	Species	Therapy/duration	Outcome
(8) PA	2014	53/M	Spinal block procedures	Motor Weakness Paresthesia	MRI (L2–L3)	Surgery Biopsy	Aspergillus spp.	Laminectomy, amphotericin B /30 days	Recovered
(3) PA	2015	20/M	Past pulmonary tuberculosis	Fever Back pain	MRI (T7–T12)	Biopsy histopathological	A. terreus	Voriconazole /16 days Caspofungin /40 days	Sequelae
(1) PA	2019	61/M	Lumbar steroid injection	Back pain	MRI (L3–L4)	Surgery Biopsy Histopathological	A. nidulans	Lumbar discectomy Caf /6 weeks Voriconazole /7 months Pos	Recovered
(2) PA	2020	43/M	Brucellosis-related vertebral	Back pain	MRI (L5–S1)	Biopsy Enzyme linked immunosorbent assay	Aspergillus spp.	Voriconazole/3 months	Recovered
(4) PA	2015	53/M	Pulmonary granulomatous	Fever cough Back pain	Chest CT MRI (L2–L5)	Surgery	Aspergillus spp	Voriconazole/3 months	Recovered
(7) PA	2019	71/M	Abdominal stab wound	Back pain Paresthesia	MRI (T11–T12)	Biopsy Enzyme linked immunosorbent assay Histopathological	A. terreus	Laminectomy Voriconazole/5 months	Recovered
(5) PA	2022	54/F	None	Back pain	MRI (T11-T12)	Surgery Histopathological	Aspergillus spp	Laminectomy Voriconazole /3 months	Recovered
(6) PA	2023	68/M	None	Thoracolumbar back pain	MRI (T12–L2)	Surgery Histopathological	A. fumigatus	Isavuconazole /12 months	Recovered
(10) PA	2023	58/F	None	Low back pain	MRI (L4–5)	Surgery Histopathological	A. terreus	Voriconazole /6 months	Recovered
(9) PA	2024	63/M	None	Low back pain	MRI (T12-L1)	Surgery Histopathological	A. fumigatus	Voriconazole /1 months	Recovered
Our case	2024	27/M	None	Back pain	MRI (L3–L5)	Surgery Histopathological	A. fumigatus	Voriconazole /10 weeks	Recovered